# FDA Inspection 1162462 - Southern Edge Orthopaedics - February 16, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/southern-edge-orthopaedics/fbe0e48b-76c4-4c26-808f-8581e89b08fe/
Source feed: FDA_Inspections

> FDA Inspection 1162462 for Southern Edge Orthopaedics on February 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162462
- Company Name: Southern Edge Orthopaedics
- Inspection Date: 2022-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162462 - 2022-02-16](https://www.globalkeysolutions.net/api/records/fda_inspections/southern-edge-orthopaedics/76767275-23b0-4c55-868f-7112c4db1fdc/)
- [FDA Inspection 1081454 - 2019-02-12](https://www.globalkeysolutions.net/api/records/fda_inspections/southern-edge-orthopaedics/0f8df0e8-bdbf-456a-ac71-d438507eaaf4/)

Company: https://www.globalkeysolutions.net/companies/southern-edge-orthopaedics/33cfc93b-1cce-4842-aea8-96dc53f5df2f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d